Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-11-02-2003
Volume27
Issue 11

Clearing Regulatory Hurdles

Author(s):

Christopher C. DeMerlis

The authors propose several models for independent evaluation of new excipients.

External Link - article-75179.pdf

Articles in this issue
FDA Will Drive Changes for Contract Business
In the Spotlight--December
Novemember 2003
FDA Seeks Risk-Based Inspection Program
Routine Sample Size for a Retest Procedure
November 2003

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
PharmTech Weekly News Roundup
Related Content
Ozempic, Mounjaro and Wegovy injectable pens on white background | Image Credit: © K KStock - stock.adobe.com
September 17th 2025

Lilly, Novo, Hims Get FDA Warnings About Misleading Drug Communications

Patrick Lavery
Drug Solutions Podcast: Sustainable Solutions for Biopharma
September 17th 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
Site Logo
September 17th 2025

Bringing novel ADC formats into the clinic

Lonza
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
September 17th 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
Site Logo
September 17th 2025

BETTER, FASTER SMALL-MOLECULE SYNTHESIS: LEVERAGING MODERN TOOLS TO EVALUATE AND OPTIMIZE PROCESS CHEMISTRY

Lonza
Digital composite of highlighted red painful liver of woman | Image credit: ©mi_viri -stock.adobe.com
September 17th 2025

Competition in MASH is Heating Up as GLP-1s Gate-Crash the Party

Cheryl Barton
© 2025 MJH Life Sciences

All rights reserved.